Wendler Sergej, Otto Andreas, Ortseifen Vera, Bonn Florian, Neshat Armin, Schneiker-Bekel Susanne, Walter Frederik, Wolf Timo, Zemke Till, Wehmeier Udo F, Hecker Michael, Kalinowski Jörn, Becher Dörte, Pühler Alfred
Senior Research Group in Genome Research of Industrial Microorganisms, Center for Biotechnology, Bielefeld University, Universitätsstraße 27, 33615 Bielefeld, Germany.
Institute for Microbiology, Ernst-Moritz-Arndt-University of Greifswald, F.-L. Jahnstrasse 15, 17489 Greifswald, Germany.
J Proteomics. 2015 Jul 1;125:1-16. doi: 10.1016/j.jprot.2015.04.013. Epub 2015 Apr 18.
Acarbose is an α-glucosidase inhibitor produced by Actinoplanes sp. SE50/110 that is medically important due to its application in the treatment of type2 diabetes. In this work, a comprehensive proteome analysis of Actinoplanes sp. SE50/110 was carried out to determine the location of proteins of the acarbose (acb) and the putative pyochelin (pch) biosynthesis gene cluster. Therefore, a comprehensive state-of-the-art proteomics approach combining subcellular fractionation, shotgun proteomics and spectral counting to assess the relative abundance of proteins within fractions was applied. The analysis of four different proteome fractions (cytosolic, enriched membrane, membrane shaving and extracellular fraction) resulted in the identification of 1582 of the 8270 predicted proteins. All 22 Acb-proteins and 21 of the 23 Pch-proteins were detected. Predicted membrane-associated, integral membrane or extracellular proteins of the pch and the acb gene cluster were found among the most abundant proteins in corresponding fractions. Intracellular biosynthetic proteins of both gene clusters were not only detected in the cytosolic, but also in the enriched membrane fraction, indicating that the biosynthesis of acarbose and putative pyochelin metabolites takes place at the inner membrane.
Actinoplanes sp. SE50/110 is a natural producer of the α-glucosidase inhibitor acarbose, a bacterial secondary metabolite that is used as a drug for the treatment of type 2 diabetes, a disease which is a global pandemic that currently affects 387 million people and accounts for 11% of worldwide healthcare expenditures (www.idf.org). The work presented here is the first comprehensive investigation of protein localization and abundance in Actinoplanes sp. SE50/110 and provides an extensive source of information for the selection of genes for future mutational analysis and other hypothesis driven experiments. The conclusion that acarbose or pyochelin family siderophores are synthesized at the inner side of the cytoplasmic membrane determined from this work, indicates that studying corresponding intermediates will be challenging. In addition to previous studies on the genome and transcriptome, the work presented here demonstrates that the next omic level, the proteome, is now accessible for detailed physiological analysis of Actinoplanes sp. SE50/110, as well as mutants derived from this and related species.
阿卡波糖是由游动放线菌SE50/110产生的一种α-葡萄糖苷酶抑制剂,因其在2型糖尿病治疗中的应用而具有重要医学意义。在本研究中,对游动放线菌SE50/110进行了全面的蛋白质组分析,以确定阿卡波糖(acb)和假定的绿脓菌素(pch)生物合成基因簇中蛋白质的定位。因此,采用了一种综合的先进蛋白质组学方法,结合亚细胞分级分离、鸟枪法蛋白质组学和光谱计数来评估各分级中蛋白质的相对丰度。对四种不同的蛋白质组分级(胞质、富集膜、膜刮取物和细胞外分级)进行分析,结果在8270个预测蛋白质中鉴定出1582个。检测到了所有22个Acb蛋白和23个Pch蛋白中的21个。在相应分级中最丰富的蛋白质中发现了pch和acb基因簇预测的膜相关、整合膜或细胞外蛋白质。两个基因簇的细胞内生物合成蛋白不仅在胞质分级中被检测到,在富集膜分级中也被检测到,这表明阿卡波糖和假定的绿脓菌素代谢产物的生物合成发生在内膜。
游动放线菌SE50/110是α-葡萄糖苷酶抑制剂阿卡波糖的天然生产者,阿卡波糖是一种细菌次级代谢产物,用作治疗2型糖尿病的药物,2型糖尿病是一种全球大流行疾病,目前影响3.87亿人,占全球医疗保健支出的11%(www.idf.org)。本文介绍的工作是对游动放线菌SE50/110中蛋白质定位和丰度的首次全面研究,为未来突变分析和其他假设驱动实验的基因选择提供了广泛的信息来源。根据这项工作得出的阿卡波糖或绿脓菌素家族铁载体在细胞质膜内侧合成的结论表明,研究相应的中间体将具有挑战性。除了先前对基因组和转录组的研究外,本文介绍的工作表明,下一个组学水平,即蛋白质组,现在可用于对游动放线菌SE50/110以及由此衍生的突变体和相关物种进行详细的生理分析。